Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial.
Joosten LPT, van Doorn S, Hoes AW, Nierman MC, Wiersma NM, Koek HL, Hemels MEW, Huisman MV, Roes KC, van den Bor RM, Buding WF, Rutten FH, Geersing GJ. Joosten LPT, et al. BMJ Open. 2019 Dec 29;9(12):e032488. doi: 10.1136/bmjopen-2019-032488. BMJ Open. 2019. PMID: 31888928 Free PMC article.
Sex- and age specific association of new-onset atrial fibrillation with in-hospital mortality in hospitalised COVID-19 patients.
Offerhaus JA, Joosten LPT, van Smeden M, Linschoten M, Bleijendaal H, Tieleman R, Wilde AAM, Rutten FH, Geersing GJ, Remme CA; CAPACITY-COVID collaborative consortium. Offerhaus JA, et al. Among authors: joosten lpt. Int J Cardiol Heart Vasc. 2022 Apr;39:100970. doi: 10.1016/j.ijcha.2022.100970. Epub 2022 Feb 4. Int J Cardiol Heart Vasc. 2022. PMID: 35136831 Free PMC article.
Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial.
Joosten LPT, van Doorn S, van de Ven PM, Köhlen BTG, Nierman MC, Koek HL, Hemels MEW, Huisman MV, Kruip M, Faber LM, Wiersma NM, Buding WF, Fijnheer R, Adriaansen HJ, Roes KC, Hoes AW, Rutten FH, Geersing GJ. Joosten LPT, et al. Circulation. 2024 Jan 23;149(4):279-289. doi: 10.1161/CIRCULATIONAHA.123.066485. Epub 2023 Aug 27. Circulation. 2024. PMID: 37634130 Free article. Clinical Trial.